Beta-AARC

The project 'Beta-AARC: Cohort study for the identification of blood biomarkers in the population with subjective cognitive decline', underway from 2021, deepens the knowledge of the factors that influence the onset of Alzheimer's disease and the detection of biomarkers to identify people at increased risk of developing the disease before the first symptoms appear. It is a cohort study that will include approximately 200 people aged between 55 and 80 who experience a subjective deterioration of memory or other cognitive abilities, such as attention, planning ability or orientation.